---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-040656"
form_type: "8-K"
ticker: "NVAX"
cik: "0001000694"
company_name: "NOVAVAX INC"
filed_at: "2025-04-29T23:59:59+00:00"
generated_at: "2026-05-23T03:17:51.609302+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Novavax appoints Charles W. Newton to Board, increasing size to nine members

## Summary
- Board expanded from 8 to 9 members; Charles W. Newton appointed as Class III director effective April 25, 2025.
- Newton receives initial equity grant of 42,840 stock options and 28,560 RSUs ($525,000 grant-date fair value).
- Annual equity grants valued at $350,000 will begin after the 2026 Q2 board meeting.
- Board affirms Newton qualifies as independent under Nasdaq standards; no related-party transactions.
- Standard indemnification agreement to be entered with Novavax.

## SEC filing metadata
- accession: 0001104659-25-040656
- form_type: 8-K
- ticker: NVAX
- cik: 0001000694
- company_name: NOVAVAX INC
- filed_at: 2025-04-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000694/000110465925040656/0001104659-25-040656-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000694/000110465925040656/tm2513372d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-040656
- JSON: https://secwatch.observer/filing/0001104659-25-040656.json
- Plain text: https://secwatch.observer/filing/0001104659-25-040656.txt

## Key facts
- Executive change
  Charles W. Newton was appointed as Class III director at NOVAVAX INC.
  - Action: appointed
  - Role: Class III director
  source text: appointed Charles W. Newton. to the Board, effective on such date, to fill the resulting vacancy and to serve as a Class III director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1000694/000110465925040656/0001104659-25-040656-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.